Intelligence / Healthtech / New Clinical Trials
ClinicalLIVEUpdated 18 Nov 2026
New Clinical Trials
Clinical trials companies registered in the last 30 days, worldwide, with the sponsor, phase and countries.
Sources: ClinicalTrials.gov · Rebuilt weekly · Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase.
Trials
777
in the 30 days to 2026-11-18
Added in 30 days
777
to 18 Nov 2026
Top country
United States
192 · 25% of the list
Phase covered
8
distinct values
Snapshot · 18 Nov 2026
Explore all 777 Growth
By month
777
Signals
What the register says this week, and why it matters if you sell into it.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
- 174 of the listed studies are device, diagnostic or digital-health studies (no drug phase).
- A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
PostedSponsorStudyPhaseStatus
18 Nov 2026CellinCellsSouth KoreaDevelopment of an ASRS-Based Photoguide for a Clinical Trial of TRTP-101 in Adults With Atrophic ScarsNot Yet Recruiting17 Nov 2026AstraZenecaUnited States, Argentina, AustraliaA Study to Investigate the Efficacy and Safety of Dato-DXd-based Combinations in Participants With TROP2 NMR+ NSCLCPhase 2Not Yet Recruiting17 Nov 2026Boryung Biopharma Co., Ltd.South KoreaA Study to Evaluate the Efficacy and Safety of BRC-201 in Patients With Acute Uncomplicated InfluenzaPhase 3Recruiting17 Nov 2026NS Pharma, Inc.United States, Australia, CanadaA Global Phase 2 Extension Study of Brogidirsen in Boys With Duchenne Muscular DystrophyPhase 2Enrolling By Invitation16 Nov 2026DALIM TISSEN Co., Ltd.South KoreaSafety and Efficacy of BioSeal as a Surgical Adhesive in Cardiovascular SurgeryNot applicableRecruiting16 Nov 2026Hanmi Pharmaceutical Company LimitedSouth KoreaA Study to Evaluate the Pharmacokinetics and Safety Between HIP2604 and RLD2606 in Healthy VolunteersPhase 1Not Yet Recruiting13 Nov 2026GC Biopharma CorpSouth KoreaPhase 2 Study of GC4006A in Healthy AdultsPhase 2Enrolling By Invitation13 Nov 2026Jeil Pharmaceutical Co., Ltd.South KoreaObservational Study With Erosive Gastroesophageal Reflux Disease With JAQBO® ODTCompleted13 Nov 2026Korea United Pharm. Inc.South KoreaSafety and Pharmacokinetics of UI112 Compared With UIC202611 in Healthy AdultsPhase 1Not Yet Recruiting12 Nov 2026AstraZenecaChina, Hong Kong, MalaysiaA Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin, and Placebo on LDL-C in LLT-naïve PatientsPhase 3Not Yet Recruiting12 Nov 2026Daewon Pharmaceutical Co., Ltd.South KoreaClinical Trial to Evaluate the Safety and Efficacy of DW4421 in Patients With Erosive Reflux DiseasePhase 3Completed12 Nov 2026HK inno.N CorporationSouth KoreaEfficacy and Safety of Kabalin Cap.(Pregabalin) in Patients With Neuropathic PainRecruiting12 Nov 2026HK inno.N CorporationSouth KoreaBlood Pressure Control and Safety of Ex-one or Ex-one Plus in Essential HypertensionRecruiting12 Nov 2026Novo Nordisk A/SUnited States, Argentina, BrazilA Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at Lower Dose Levels in People With Type 2 Diabetes Treated With Metformin, Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i), or BothPhase 3Not Yet Recruiting12 Nov 2026Novo Nordisk A/SUnited States, Brazil, ChinaA Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease Treated With Once Daily Basal Insulin Alone or in Combination With Metformin, SGLT2i, or BothPhase 3Not Yet Recruiting12 Nov 2026Txinno Bioscience Inc.South KoreaPhase 1b/2 to Evaluate the Safety, Tolerability, and Efficacy of TXN10128 in Combination With TOPO-I Inhibitor-based Therapies (Irinotecan or TROP2 ADC) in Advanced or Metastatic EGFR Mutated NSCLCPhase 1, Phase 2Recruiting10 Nov 2026HK inno.N CorporationSouth KoreaObservational Study to Evaluate the Safety and Efficacy of Kremezin IDT/Fine Gran in Progressive Chronic Kidney Disease Patients.Recruiting9 Nov 2026Boehringer IngelheimUnited States, Belgium, FinlandA Study to Test Whether BI 3810477 Helps People With Idiopathic Pulmonary Fibrosis When Taken With or Without Standard TreatmentPhase 2Not Yet Recruiting9 Nov 2026Boehringer IngelheimUnited States, Australia, JapanA Study of BI 4015092, Alone or in Combination With Other Cancer Treatment, in Patients With Advanced Cancer That Has a KRAS G12D MutationPhase 1Not Yet Recruiting9 Nov 2026HK inno.N CorporationSouth KoreaObservational Study to Evaluate Achieving LDL-cholesterol Target Level to Treat With Rovazet Tab. With Dyslipidemia PatientsRecruiting6 Nov 2026BELL Therapeutics Inc.South KoreaSmartphone Camera Measurement of Breathing-Related Heart Rate Variability Compared With ECG in Healthy AdultsNot applicableNot Yet Recruiting6 Nov 2026HK inno.N CorporationSouth KoreaEfficacy and Safety of K-CAB(Tegoprazan) 25 mg as Maintenance Therapy Following the Treatment of GERDRecruiting5 Nov 2026Novo Nordisk A/SUnited States, Argentina, AustraliaA Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and ObesityPhase 3Not Yet Recruiting4 Nov 2026Boehringer IngelheimUnited States, Argentina, AustriaA Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)Phase 3Not Yet Recruiting3 Nov 2026Yuhan CorporationSouth KoreaBioequivalence Study Between YHP2508A and YHR2601 in Healthy SubjectsPhase 1Recruiting3 Nov 2026Yuhan CorporationSouth KoreaBioequivalence Study Between YHP2508B and YHR2602 in Healthy SubjectsPhase 1Recruiting30 Oct 2026ATEMs Co., Ltd.South KoreaClinical Trial of Type II Collagen vs. Sodium Hyaluronate Intra-articular Injection in Knee OsteoarthritisNot applicableCompleted28 Oct 2026AJU Pharm Co., Ltd.South KoreaA Bioequivalence and Safety Study of AJU-B718 and B718R in Healthy Adult Volunteers Under Fasting ConditionsPhase 1Not Yet Recruiting28 Oct 2026AJU Pharm Co., Ltd.South KoreaA Bioequivalence and Safety Study of AJU-C719 and C719R in Healthy Adult VolunteersPhase 1Not Yet Recruiting28 Oct 2026Eli Lilly and CompanyUnited States, Argentina, AustraliaA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular RiskPhase 3Not Yet Recruiting27 Oct 2026BIONEER CorporationSouth KoreaEfficacy and Safety of CosmeRNA-ARI Anti Hair Loss Tonic in Adults With Androgenetic AlopeciaNot applicableCompleted27 Oct 2026Hanmi Pharmaceutical Company LimitedSouth KoreaA Study to Evaluate Efficacy and Safety of HIP2602 in Erectile Dysfunction PatientsPhase 3Recruiting26 Oct 2026Jeil Pharmaceutical Co., Ltd.South KoreaPost-Marketing Surveillance to Evaluate the Safety and Effectiveness of Zastaprazan CitrateRecruiting23 Oct 2026CellinCellsSouth KoreaCIC101-02-LT is a Long-term Follow-up Study of Participants Treated With TRTP-101 and Will Evaluate the Long-term Safety and Efficacy of TRTP-101.Recruiting22 Oct 2026Janssen Korea, Ltd., KoreaSouth KoreaA Study of Opsynvi in Adults Participants With Pulmonary Arterial Hypertension in KoreaNot Yet Recruiting20 Oct 2026GC Biopharma CorpSouth KoreaClinical Trial to Evaluate the Immunogenicity and Safety of GC3114B in Adults Aged 65 Years or OlderPhase 2, Phase 3Recruiting// How AOS uses this